![]() Press Release Distribution |
Filter News Show All ResultsNews By Country
News By Tag Cancer ![]() Tumor ![]() Related Tags Breast
Breast Cancer Cancer Research Cancer Symptoms Cancer Treatment Charity Chemotherapy Diabetes Disease Fundraiser Health Healthcare Hospital Lung Cancer Medical Oncology Research Therapy Treatment Tumor
| cancer and tumor News+ XML/RSSBy Austin Dentist Family Tree Dental Group Examines the Risks and Benefits of Dental X-Rays By Caring for Carcinoid Foundation The Board of Directors of the Caring for Carcinoid Foundation is pleased to announce the appointment of Ron Hollander as its new Executive Director. By National Canine Cancer Foundation Two pre-eminent organizations fighting to eliminate cancer in dogs, strive to do it together! Chase Away K9 Cancer will now direct their fundraising efforts towards research grants approved through the National Canine Cancer Foundation. By Central Park Communications Steven Olson of the University of Illinois at Chicago College of Dentistry has received a $3.12 million federal grant for research on anticoagulant proteins that regulate blood clotting and prevent abnormal clotting. All Press ReleasesBy Austin Dentist Family Tree Dental Group Examines the Risks and Benefits of Dental X-Rays By Harrison Edwards PR Charity Outing Will Support Foundation’s Leading Edge Brain Cancer Research & Clinical Trials in the Greater New York Metropolitan Area - One Lucky Golfer Who Hits a Hole-in-One Will Win a New Porsche 911 Carrera, Courtesy of Pepe Porsche By Caring for Carcinoid Foundation The Board of Directors of the Caring for Carcinoid Foundation is pleased to announce the appointment of Ron Hollander as its new Executive Director. By Caring for Carcinoid Foundation The Caring for Carcinoid Foundation (CFCF) is pleased to announce its celebratory programming in honor of Worldwide NET Cancer Awareness Day. CFCF-sponsored events include a Patient Education Seminar and awarding grants to patient support groups. By National Canine Cancer Foundation Two pre-eminent organizations fighting to eliminate cancer in dogs, strive to do it together! Chase Away K9 Cancer will now direct their fundraising efforts towards research grants approved through the National Canine Cancer Foundation. By Central Park Communications Steven Olson of the University of Illinois at Chicago College of Dentistry has received a $3.12 million federal grant for research on anticoagulant proteins that regulate blood clotting and prevent abnormal clotting. By Fast Market Research New Medical Devices research report from GlobalData is now available from Fast Market Research By Frank Groff Inc. Surgeon to Remove Potentially Deadly Tumor near Brainstem By Binghamton University Many new cancer weapons come as personalized therapies that can target specific changes in an individual’s tumor. Leading the work are Binghamton University researchers who are using a new tool in studying tubulin tyrosine ligase, or TTL enzyme. By Elegance Vie Corp. Immunolizer® is a natural formula scientifically designed to optimize the immune system's performance. Immunolizer® activates the body's defense mechanisms and helps the Immune System to distinguish adequately between self and non-self. Dr Sanjay Maheshwari Head of MP Birla Group of Hospitals visits Shridhar University Pilani Rajasthan By Shridhar University As the Guinness Record holder for operating a 66kg tumor, Dr Makeshwari takes his inspiration from Apple CEO Steve Jobs quote "Innovation distinguishes between a leader and follower." By South Nassau Communities Hospital The study revealed that when the loss of heterozygosity (LOH) was identical (concordant) in the tumors they were metastatic. New multifocal primary cancers had discordant LOH, meaning their LOH was not identical. By Jeffrey S. Musmacher Several milestones achieved following its first year treating patients in Suffolk County, New York. By Bharatbook Avastin (bevacizumab; Genentech/Roche/Chugai) is a humanized monoclonal antibody directed towards vascular endothelial growth factor (VEGF). VEGF plays an important role in angiogenesis, a key driver of tumor growth. By A. Schulz Visualase Inc. Selected to Present at Epilepsy Conference Highlighting New and Promising Epilepsy Therapies. Epilepsy Pipeline Update 2010 to Take Place February 25-26 in San Francisco. By reports-research.com The new Business Insights report Cancer Market Outlook to 2014: Competitive landscape, market size, pipeline analysis and growth opportunities looks into what the future holds for players in the fastest growing pharmaceutical market. By Andres Schulz Visualase Inc. was selected for a $2.1 million grant from the Cancer Prevention and Research Institute of Texas. The precision and control of the Visualase technology has made possible the ablation of tissue in areas such as brain and prostate. By Natural Energy Products Ganoderma or Reishi the (The King of Herbs) . Traditional Chinese Medicine has use this herb for over 4000yrs. Ganoderma has been known to treat most illnesses known to the human body By Natural Energy Products Ganoderma or Reishi the (The King of Herbs) . Traditional Chinese Medicine has use this herb for over 4000yrs. Ganoderma has been known to treat most illnesses known to the human body. By Wiseman Research Initiatives LLC A study to develop a new genetically engineered vaccine opened officially Oct 16. The program has begun screening patients. Initial clinical trial reported rapid shrinkage and/or disappearance of widespread tumors within eight weeks. By Blogging in B Minor Blogging in B Minor (markmillermusic.org/blog) chronicles Mark Miller's journey as a grade 4 brain tumor survivor and provides other brain tumor survivors with in-depth research information and personal experience to provide hope and encouragement. By GTCbio Kenna Anderes of Pfizer Global R&D, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference on January 14-15, 2008. | ||||||||||||||||||||||